Key result
A 23-year-old male developed probable clozapine-induced parenchymal lung disease and perimyocarditis one week after starting treatment for schizophrenia.
Why the study?
Does clozapine cause concurrent perimyocarditis and parenchymal lung disease in patients with schizophrenia?
Case Report (n=1)
No
Does clozapine cause concurrent perimyocarditis and parenchymal lung disease in patients with schizophrenia?
Clozapine can rarely cause concurrent perimyocarditis and parenchymal lung disease, which should be considered as a diagnosis of exclusion in patients presenting with respiratory distress and heart failure after starting the drug.
No takes yet. Share an insight, caveat, or question.
May support clozapine as rare cause of concurrent perimyocarditis and lung disease; hypothesis-generating and should not yet change practice.
Bugge et al. (2016) conducted a case report in Schizophrenia (n=1). Clozapine was evaluated on Development of adverse effects (parenchymal lung disease and perimyocarditis). A 23-year-old male developed probable clozapine-induced parenchymal lung disease and perimyocarditis one week after starting treatment for schizophrenia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: